MED Stock Medifast, Inc.
US · NYSELast in our picks 2026-10-01 — not in the current list; analysis below is from that screen
Deep value recovery candidate if operating trends stabilize and buyers return.
Future value: $18.00 (+56.25%) · 6-12 months
Signal breakdown
- ▸Institutional interest, but higher execution risk.
- ▾Below 50-day MA (-0.51%)
- ▸Above 200-day MA — long-term uptrend
- ▸~56% upside to price target
Is MED a buy right now?
Trend: MED is trading above the 50-day average (+1.59%), RSI 31 — neutral momentum, with a 3-month return of +24.21%.
Valuation & quality: Medifast, Inc. trades on forward P/E -43.3, PEG 0.97, price-to-book 0.63; fundamentals show net margin -8.1%, return on equity -12.4%, revenue growth -27.6% year on year.
Analyst consensus: 1 analysts have a mean 12-month price target of $12.00 (-0.9% vs the last close; range $12.00 – $12.00), consensus rating “none”.
Our screen: BUY (score 2) — Deep value recovery candidate if operating trends stabilize and buyers return.
Computed from end-of-day data; not personal advice.
12-month price chart
Monthly returns
| Mar 26 | Apr 26 | May 26 | Jun 26 | Jul 26 | Aug 26 | Sep 26 | Oct 26 |
|---|---|---|---|---|---|---|---|
| -3.20% | +6.70% | +15.30% | -15.30% | -7.40% | +23.50% | -5.10% | +5.10% |
Fundamentals
Analyst price target
Technical signals
About Medifast, Inc.
Medifast, Inc., through its subsidiaries, operates as a health and wellness company that provides habit-based and coach-guided lifestyle solutions for weight loss in the United States.
Sector: Consumer Cyclical · Industry: Personal Services · United States · 380 employees · Website
Related Consumer Staples picks
Browse: all US stocks · Consumer Staples picks · today's movers
Market data from end-of-day feeds; AI-generated research for educational purposes only — not investment advice.